Related Experiment Videos
Fungal pneumonias. Part 3. Allergic bronchopulmonary aspergillosis
Abstract:
Allergic bronchopulmonary aspergillosis (ABPA) is receiving increased recognition as a cause of respiratory disease. The clinical, immunologic, and radiologic features of this disease are reviewed with a discussion of possible pathophysiologic mechanisms. One approach to the diagnosis of this disorder incorporates the criteria of bronchospasm, pulmonary infiltrates, skin-test reactivity to and precipitating antibodies against Aspergillus antigen, eosinophilia, elevated IgE levels, and classic bronchographic findings. Steroids appear to be the drug of choice in ABPA, but specific therapeutic regimens will require further long-term studies. The IgE levels may prove to be useful in following the course of this disease and in aiding decisions regarding duration of therapy.
Insights
Allergic bronchopulmonary aspergillosis (ABPA) is an emerging respiratory illness. Diagnosis involves specific clinical, immunologic, and radiologic criteria, with steroids as a primary treatment, and IgE levels aiding management.
Area of Science:
- Pulmonology
- Immunology
- Infectious Diseases
Background:
- Allergic bronchopulmonary aspergillosis (ABPA) is increasingly recognized as a significant respiratory condition.
- Understanding its clinical, immunologic, and radiologic aspects is crucial for effective management.
Purpose of the Study:
- To review the key features of ABPA.
- To discuss potential pathophysiologic mechanisms.
- To outline diagnostic criteria and therapeutic approaches.
Main Methods:
- Literature review of clinical, immunologic, and radiologic findings in ABPA.
- Discussion of diagnostic criteria including bronchospasm, infiltrates, Aspergillus reactivity, eosinophilia, elevated IgE, and bronchography.
- Review of current therapeutic strategies, primarily corticosteroids.
Main Results:
- Diagnostic criteria for ABPA have been established, integrating multiple clinical and laboratory findings.
- Corticosteroids are identified as the primary pharmacologic intervention.
- Elevated IgE levels show potential utility in monitoring disease activity and guiding treatment duration.
Conclusions:
- ABPA diagnosis relies on a composite of clinical, immunologic, and radiologic evidence.
- While steroids are the current treatment of choice, further research is needed for optimized therapeutic regimens.
- Monitoring IgE levels may be a valuable tool for assessing ABPA progression and treatment response.